Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Philips Azurion R3.0 Systems Recalled for Missing SSD Spacer

Agency Publication Date: December 9, 2025
Share:
Sign in to monitor this recall

Summary

Approximately 110 Philips Azurion R3.0 systems (Model 722234), commercially known as Azurion 7 M20 with a FlexArm stand, were shipped without a Source-to-Skin Distance (SSD) Spacer. These interventional fluoroscopic X-ray systems were distributed between July 2024 and June 2025. The missing spacer is a safety component required to maintain a minimum distance of 38 cm between the X-ray source and the patient's skin. Healthcare facilities should contact Philips to arrange for the necessary hardware correction.

Risk

Without the SSD spacer, the X-ray source may be positioned too close to the patient during medical procedures. This increases the risk of excessive radiation exposure or skin burns to the patient.

What You Should Do

  1. This recall involves Philips Azurion R3.0 systems (Azurion 7 M20) with a FlexArm stand, shipped between July 2024 and June 2025. Affected units are identified by Model Number 722234 and Philips Reference C&R 2025-IGT-BST-016.
  2. Verify if your medical facility has an affected system by checking the model number on the device label and confirming if it is equipped with a FlexArm stand and the required SSD Spacer.
  3. Stop using the recalled device for standard fluoroscopy applications where the minimum source-to-skin distance cannot be guaranteed. Contact Philips North America or your authorized distributor to arrange for a hardware correction or replacement.
  4. Call the FDA Consumer Complaint hotline at 1-888-463-6332 for additional questions regarding medical device recalls.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Azurion R3.0 (Azurion 7 M20) Interventional Fluoroscopic X-Ray System
Variants: FlexArm stand configuration
Model / REF:
722234
Date Ranges: Shipped July 2024 โ€” June 2025

Philips Reference C&R 2025-IGT-BST-016; Quantity affected: 110 units.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 98052
Status: Active
Manufacturer: Philips North America
Sold By: Philips North America; Authorized medical equipment distributors
Manufactured In: United States
Units Affected: 110
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.